Browsing Tag
Roche Holding AG
13 posts
Atezolizumab slashes colon cancer recurrence by 50% in ATOMIC trial: ASCO 2025 breakthrough
Genentech’s Tecentriq cuts recurrence risk by 50% in dMMR colon cancer, setting the stage for new adjuvant approvals after ATOMIC trial success.
MicroAlgo crashes 20%, Trump Media slips again—here’s why markets panicked
Explore why 25 top U.S.-listed stocks tumbled on April 2 as Trump’s tariff strategy ignited fears of inflation, recession, and global retaliation.
How Roche’s new deal with LumiraDx will transform Point of Care testing forever
Roche Holding AG has finalised its acquisition of LumiraDx’s innovative Point of Care technology, a strategic move aimed…